THE HPV AND ANAL CANCER FOUNDATION LIMITED
The HPV and Anal Cancer Foundation is dedicated to empowering anal cancer patients and accelerating prevention and research methods that eliminate anal cancer and the virus that causes the majority of cases, HPV.
Financial health, per its FY2024 accounts
The accounts state that the charity incurred a net expenditure of £105,040 for the year, resulting in a decrease in total funds from £294,755 to £189,715. Per the trustees' report, free reserves of £176,615 remain above the stated policy target of £32,421, and the trustees consider the charity to be a going concern with a comfortable level of reserves.
What the accounts disclose
Structured financials (annual return, FY ending 31/12/2023)
Trustees
- TRISTAN ALMADAchair
- CAMILLE ALMADA
- JUSTINE ALMADA
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £64k | £169k |
| 31/12/2023 | £580k | £343k |
| 31/12/2022 | £155k | £173k |
| 31/12/2021 | £205k | £256k |
| 31/12/2020 | £90k | £129k |
Common questions
Is THE HPV AND ANAL CANCER FOUNDATION LIMITED financially healthy?
Per its FY2024 accounts: The accounts state that the charity incurred a net expenditure of £105,040 for the year, resulting in a decrease in total funds from £294,755 to £189,715. Per the trustees' report, free reserves of £176,615 remain above the stated policy target of £32,421, and the trustees consider the charity to be a going concern with a comfortable level of reserves. Its FY2024 accounts were independently examined.
Who funds THE HPV AND ANAL CANCER FOUNDATION LIMITED?
Funders whose own accounts filings name THE HPV AND ANAL CANCER FOUNDATION LIMITED as a grant recipient include BACON FOUNDATION LTD.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| BACON FOUNDATION LTD | FY2024 | £10k | Support the NOMAN Campaign |